← til store investorer
Kynam Capital Management, LP
kapitalforvalter · portefølje $1.81 mia. · 32 positioner · rapport pr. 30.06.2026
Aktiepositioner rapport for 30.06.2026, indsendt 14.08.2026; ændring — mod 31.03.2026 · 0
| Selskab | Aktier | Værdi | % af porteføljen | Ændring i kvartalet |
|---|
I virksomheder i vores database 14
| Selskab | Andel | Aktier | Rapportdato |
|---|---|---|---|
| Burning Rock Biotech Ltd | 14.05% | 1 238 563 | 2026-06-30 |
| CytomX Therapeutics Inc | 9.96% | 21 703 093 | 2026-06-30 |
| Syndax Pharmaceuticals Inc | 8.94% | 8 050 959 | 2026-06-30 |
| Celldex Therapeutics Inc | 6.78% | 5 322 908 | 2026-06-30 |
| Viridian Therapeutics Inc | 5.7% | 6 453 877 | 2026-06-30 |
| Sutro Biopharma | 5.26% | 872 558 | 2026-06-30 |
| UroGen Pharma Ltd | 4.98% | 2 434 207 | 2026-06-30 |
| Cullinan Therapeutics, Inc. | 4.84% | 3 114 132 | 2026-06-30 |
| Vera Therapeutics Inc | 4% | 2 890 059 | 2026-06-30 |
| Alector Inc | 3.41% | 3 808 494 | 2026-06-30 |
| Prelude Therapeutics Inc | 3.03% | 2 415 087 | 2026-06-30 |
| Caribou Biosciences Inc | 2.34% | 2 503 302 | 2026-06-30 |
| Legend Biotech Corp | 1.55% | 3 001 205 | 2026-06-30 |
| ProQR Therapeutics BV | 1.49% | 1 566 317 | 2026-06-30 |
annonce